- Sophoricoside
-
- $0.00 / 1kg
-
2026-01-15
- CAS:152-95-4
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 1000kg
- Sophoricoside
-
- $80.00 / 1kg
-
2026-01-15
- CAS:152-95-4
- Min. Order: 1kg
- Purity: 5%-98% HPLC
- Supply Ability: 10000KG
- Sophoricoside
-
- $50.00 / 1mL
-
2026-01-14
- CAS:152-95-4
- Min. Order:
- Purity: 99.28%
- Supply Ability: 10g
|
| | Sophoricoside Basic information |
| Product Name: | Sophoricoside | | Synonyms: | 5,7-dihydroxy-3-[4-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]phenyl]-1-benzopyran-4-one;SOPHORICOSIDE;ISOGENISTIN;GENISTEIN-4'-GLUCOSIDE;GENISTEIN-4'-O-GLUCOSIDE;4H-1-Benzopyran-4-one,3-[4-(β-;D-glucopyranosyloxy)phenyl]-5,7-dihydroxy-;Sophoricoside ,98% | | CAS: | 152-95-4 | | MF: | C21H20O10 | | MW: | 432.38 | | EINECS: | | | Product Categories: | Miscellaneous Natural Products;Natural Plant Extract | | Mol File: | 152-95-4.mol |  |
| | Sophoricoside Chemical Properties |
| Melting point | 298° | | alpha | D20 -47° (pyridine); D20 -32° (10% aq pyridine) | | Boiling point | 466.08°C (rough estimate) | | density | 1.3597 (rough estimate) | | refractive index | 1.5376 (estimate) | | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | | solubility | Aqueous Base (Slightly), DMSO (Slightly, Heated), Pyridine (Slightly, Sonicated) | | form | Solid | | pka | 6.45±0.20(Predicted) | | color | White to Light Brown | | λmax | 271nm(MeOH)(lit.) | | Major Application | metabolomics
vitamins, nutraceuticals, and natural products | | InChIKey | ISQRJFLLIDGZEP-JNAFRSBINA-N | | SMILES | C12C(O)=CC(O)=CC=1OC=C(C1C=CC(O[C@H]3[C@H](O)[C@H]([C@H](O)[C@@H](CO)O3)O)=CC=1)C2=O |&1:16,17,19,20,22,r| | | CAS DataBase Reference | 152-95-4(CAS DataBase Reference) |
| Safety Statements | 22-24/25 | | WGK Germany | WGK 3 | | HS Code | 29329990 | | Storage Class | 11 - Combustible Solids |
| | Sophoricoside Usage And Synthesis |
| Chemical Properties | Light yellow solid | | Uses | Genistein 4''-β-D-glucopyranoside is a metabolite of Genistein (G350000), which exhibits specific inhibitory activity against tyrosine kinases,including autophosphorylation of epidermal growth factor receptor kinase (IC50 - 2.6uM). Also inhibits other protein kinases through competitive inhibition of ATP. Inhibits tumor cell proliferation and induces tumor cell differentiation. | | Definition | ChEBI: Sophoricoside is an isoflavonoid and an acrovestone. | | Biological Activity | Sophoricoside (SOP) improves lipopolysaccharides (LPS)-induced acute lung injury (ALI) in mice by activating the adenosine monophosphate-activated protein kinase (AMPK)/nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. It also improves contact dermatitis by inhibiting the nuclear factor-kappa B (NF-KB) pathway in B cells in mice model.', 'Sophoricoside elicits anti-cancer, immunosuppressive, and anti-inflammatory activities. It inhibits proinflammatory cytokine production in human mast cells and has the potential to tre at allergic inflammation diseases. | | in vivo | When the Sophoricoside is orally administered 1 h before compound 48/80 injections, the scratching behaviors is reduced. The inhibition rate of Sophoricoside (2 mg/kg) is approximately 41.21%. Orally administered Sophoricoside inhibits the scratching behaviors by 47.31%. When mice are treated for 2 weeks with Sophoricoside, the atopic dermatitis is recovered to a significant extent[1]. |
| | Sophoricoside Preparation Products And Raw materials |
|